This is a portfolio of gene panels associated with hereditary cardiovascular diseases.
Through Next Generation Sequencing (NGS), a wide range of genes linked to hereditary heart disease are evaluated, in accordance with current international guidelines and the recommendations of local professionals.

Portfolio of somatic studies to determine the molecular profile of solid tumors and enable the application of targeted therapy.

It integrates various panels developed under national and international clinical guidelines and focused on the field of precision medicine.

Portfolio of genetic studies for the diagnosis of hereditary cancer.

It includes everything from a family variant to specific panels designed based on national and international clinical guidelines.

The Prosigna test provides comprehensive and important information that helps breast cancer patients and their doctors choose the best treatment.